Ro07-9749 is a benzodiazepine derivative with sedative and anxiolytic effects,[1] which has been used as an internal standard in the analysis of other benzodiazepines,[2] and also sold as a designer drug.[3]

Ro07-9749
Identifiers
  • 5-(2-fluorophenyl)-7-iodo-1,3-dihydro-1,4-benzodiazepin-2-one
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H10FIN2O
Molar mass380.161 g·mol−1
3D model (JSmol)
  • C1C(=O)NC2=C(C=C(C=C2)I)C(=N1)C3=CC=CC=C3F
  • InChI=1S/C15H10FIN2O/c16-12-4-2-1-3-10(12)15-11-7-9(17)5-6-13(11)19-14(20)8-18-15/h1-7H,8H2,(H,19,20)
  • Key:UBSKLVILVGEEON-UHFFFAOYSA-N

See also

edit

References

edit
  1. ^ IL 35885, "5-(2-fluorophenyl)-1,3-dihydro-7-iodo-2h-1,4-benzodiazepin-2-one derivatives and their preparation.", issued 16 May 1974, assigned to Sparamedica AG 
  2. ^ Greenblatt DJ, Locniskar A, Ochs HR, Lauven PM (August 1981). "Automated gas chromatography for studies of midazolam pharmacokinetics". Anesthesiology. 55 (2): 176–9. doi:10.1097/00000542-198108000-00014. PMID 6114686.
  3. ^ Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Scherbaum N, Schifano F (July 2021). "The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity". Pharmaceuticals (Basel, Switzerland). 14 (8): 720. doi:10.3390/ph14080720. PMC 8398354. PMID 34451817.